Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis - Wikidata - awgldk - TriplyDB

Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis

Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis

http://www.wikidata.org/entity/Q33944689

about

Alcohol, insulin resistance and the liver-brain axis Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease Ceramide-mediated insulin resistance and impairment of cognitive-motor functions Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases Spinal cord injury causes chronic liver pathology in rats.HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?Chronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-δ agonist treatment Effects of exercise on brain functions in diabetic animal models.Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels.Mechanisms of ceramide-mediated neurodegeneration.Brain metabolic dysfunction at the core of Alzheimer's disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome.Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.Relationships between diabetes and cognitive impairment The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.The interplay between bioactive sphingolipids and steroid hormones.Limited therapeutic effect of N-acetylcysteine on hepatic insulin resistance in an experimental model of alcohol-induced steatohepatitis.The twists and turns of sphingolipid pathway in glucose regulation The Role of Ceramide in the Pathogenesis of Alcoholic Liver Disease.Mitochondrial control of cell bioenergetics in Parkinson's disease.Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Targeting ceramide metabolism in obesity.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Lipidomic Profiles in Diabetes and Dementia.Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation.Sustained Impairments in Brain Insulin/IGF Signaling in Adolescent Rats Subjected to Binge Alcohol Exposures during Development Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.

P2860

Q26991846-0C881638-4286-4361-8917-D48B0B6BE5CA Q27021700-41407C94-0772-4110-A35B-64CF14B9C1C7 Q28087030-FDB1DCB3-7593-43FD-9592-CE073BEA3E60 Q28259585-6D47381F-ACB2-4277-B5E4-142295580C98 Q30478907-FCB96098-F89D-4B98-9A78-95C6C042A55D Q30479198-FB096A90-D02B-4D4E-93A7-74C691CB77DC Q30484122-BD98A848-A260-43A2-824F-3445DA19BF21 Q33543381-C720E6EF-0AAC-4F39-9BDB-9F7E444BC520 Q33896110-DD560A04-2452-4879-953C-B7157271A2BF Q34288447-41AE5C58-488A-4047-BE1F-6A0CCCBDEC1B Q34983871-11656555-1D74-4214-8631-64E6E0CBA905 Q35276630-D301E689-9621-4DBD-AAF1-88CADAC76D1D Q35527928-2B5D10A0-BD7F-41C9-904B-250B18203C45 Q35613905-5C0F822F-D2B7-4082-95C4-8931E27C4EF3 Q35944938-CA66DDD1-4218-4908-9308-045F5AE6DED6 Q35997786-AB8AD070-C579-41B9-A63B-6A68B8D234C5 Q35997878-1521D62B-9C73-41D3-963C-31365EA6EFC4 Q35997881-766D0565-97ED-46CE-B20E-8D016D08E369 Q35997884-7D413CC8-47F4-44BD-8164-6F87EF3BC482 Q36036789-DB4495EC-E3E3-43B0-92B0-0916CEB09DCC Q36209750-C45D4743-A054-434B-AD4F-8B965474E203 Q36469896-9B894B5F-0695-4D29-A77B-FC03515FE666 Q36623114-250E824B-C169-4018-A9C2-35F4E51761F5 Q37162219-2E01781F-92DA-4205-B96A-BFCE5A222A9C Q37335385-6C881584-2409-4551-827E-D4BEA78F9EA3 Q37366549-67EF7198-81E6-495E-86C2-AD39EAB849DC Q37602608-CA560CB7-7BA6-48EA-A899-6FC1494800D8 Q37688434-03F0C4E7-910E-41D5-9473-9C71485D9E53 Q37714392-9B746D5C-7EAF-4A16-85CB-5EC22FF98156 Q37766367-54745CDD-D9F9-4AF0-A149-5B87BC98A5AE Q38618873-131F4240-3D76-43C1-A1C7-46AE70F9E6A4 Q38811534-741F4D98-A611-4496-AC2D-EB2FE3063823 Q38830118-B8635F6D-AF93-4FA0-8E40-3A947EA13D7D Q38833111-BD3D7600-22C1-45B0-AB97-130215B82118 Q38887432-3DB66B37-41C4-42A8-A60E-81550F636A40 Q39042377-6F9012C8-8C54-4598-BD63-FD65D7FDB391 Q39352421-41A38DAF-7F04-4586-B92F-1FB3B0BB5A11 Q39569591-2561A2AE-8CAF-441F-89CB-1A323AE4B3B9 Q41952798-16AA4DAD-F5E7-4E17-BA54-7925CD95A9C4 Q46426783-7A5A53A4-9095-4321-AD8A-D44CC77D54F6

P2860

Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis

http://www.wikidata.org/entity/Q33944689

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hepatic ceramide may mediate b ...... non-alcoholic steatohepatitis

@ast

Hepatic ceramide may mediate b ...... non-alcoholic steatohepatitis

@en

type

label

Hepatic ceramide may mediate b ...... non-alcoholic steatohepatitis

@ast

Hepatic ceramide may mediate b ...... non-alcoholic steatohepatitis

@en

prefLabel

Hepatic ceramide may mediate b ...... non-alcoholic steatohepatitis

@ast

Hepatic ceramide may mediate b ...... non-alcoholic steatohepatitis

@en

P1433

Q33944689-16F6B6A0-2A63-4DF9-AE06-4F4A15ED628C

P1476

Q33944689-447AAA24-F738-4FDA-AE2A-431DA28A33DD

P2093

Q33944689-00CD8085-802E-428E-B608-20BEA96099AC

Q33944689-0512543C-785C-40EF-A208-0F63FF0F02F3

Q33944689-13935F1F-6ADF-422E-B785-58AE48CE67CE

Q33944689-1A35A95A-2BFE-4C70-879A-25F2E8302C92

Q33944689-4FA6CA25-05DE-4555-B649-0EFD2B26502E

Q33944689-7DC94F5D-FAB1-44A2-8406-36182AAE94FC

Q33944689-AA391C08-3090-4BAF-BEDF-2D8E538B1C38

Q33944689-B28BDDBA-DDC4-4BB3-BBB3-53D566F8C50C

Q33944689-BD2620D9-2B0A-4F61-9A57-B6D43F00F5F1

Q33944689-DB72C86D-EF7F-429C-B9CA-2DD3EBA06AD0

P2860

Q33944689-01DDC340-545F-470B-8CA7-25B78F3AC0AD

Q33944689-04F75330-0A97-4927-BC08-4B9886FFC909

Q33944689-0FB83239-4DB2-44BF-A337-BD88E2551DFC

Q33944689-10582B07-37EA-4025-BF59-A0A448D1751A

Q33944689-10670366-A7C0-434C-8F14-C88F0B62FFB3

Q33944689-14A0D577-B6B9-450E-8B08-E7006A1F1579

Q33944689-162B3730-E6BF-4343-8351-76B909B25ADE

Q33944689-1A68D2FB-965F-4581-A559-CE5913CDAFFC

Q33944689-1BBFF72F-1EDA-4FF9-B7F3-06E4F486175B

Q33944689-26D5BBF2-231B-4B2E-91F6-AB93D6D9635F

P304

Q33944689-D7575707-D8AC-4F4A-848F-8A4A390813B4

P31

Q33944689-A75CCA63-28A1-45B0-B4C9-9C55656D0B6D

P356

Q33944689-70543361-B978-4318-AE08-56017B77D639

P433

Q33944689-DCCDD36A-4B56-43C6-A93E-4A5BC54297DB

P478

Q33944689-C90DDB81-F0E5-4DFF-BB9E-B09096830357

P577

Q33944689-99165646-AAD3-48CC-8A82-CF74984543BB

P698

Q33944689-A889A9B9-93F2-48A0-A1BA-6438E22CCA2A

P921

Q33944689-0982E2E1-FF57-4600-9C9F-A80796BE309B

Q33944689-7E053D9D-1387-4C6A-B8AF-6938B40D19F6

Q33944689-95A2AE78-59B5-4E61-9DEC-CCFAF4D960C4

P932

Q33944689-BC74F8B2-8AC5-42B8-9C5B-20622F7476A7

P356

P1433

Journal of Alzheimer's Disease

P1476

Hepatic ceramide may mediate b ...... non-alcoholic steatohepatitis

@en

P2093

Elizabeth Silbermann

http://www.w3.org/2001/XMLSchema#string

Haiyan Xu

http://www.w3.org/2001/XMLSchema#string

Jack R Wands

http://www.w3.org/2001/XMLSchema#string

Lascelles E Lyn-Cook

http://www.w3.org/2001/XMLSchema#string

Lisa Longato

http://www.w3.org/2001/XMLSchema#string

Margot Lawton

http://www.w3.org/2001/XMLSchema#string

Ming Tong

http://www.w3.org/2001/XMLSchema#string

Ping Jiao

http://www.w3.org/2001/XMLSchema#string

Princess Mark

http://www.w3.org/2001/XMLSchema#string

Suzanne M de la Monte

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian Lass6 and its related family members regulate synthesis of specific ceramides

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver

Ethanol impairs insulin-stimulated neuronal survival in the developing brain: role of PTEN phosphatase.

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model.

Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain.

Sphingomyelinases in cell regulation.

Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth.

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.

P304

715-729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2009-0984

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19387108

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

type-2 diabetes

P932

2893047

http://www.w3.org/2001/XMLSchema#string